Duke enrolls first-in-nation children for Pfizer-BioNTech U.S. clinical study trial in children under 12
Twin 9-year-old girls at Duke Health became the first in the United States to participate in Pfizer and BioNTech Phase 1 study to evaluate safety, tolerability and immunogenicity of the Pfizer-BioN
2019 and 2020 Research Staff Award winners
Both the 2019 and 2020 Research Staff Appreciation Award winners are listed here. The announcement of last year’s awardees was delayed due to the COVID-19 pandemic.
A Year Like No Other - A Video of Thanks Highlighting the School of Medicine's Response to COVID-19
Duke University School of Medicine Ranks Third in Nation for Research
Prostate cancer uses metabolic switch to thrive after hormone therapy
Studying the cellular metabolism of prostate cancer, a team of Duke Health-led researchers identified a key reason hormone therapies eventually fail, while also laying out a way to bypass the probl
School of Medicine Faculty, Staff Receive Prestigious 2020 Duke Presidential Awards
School of Medicine faculty and staff were among the recipients of Duke University’s prestigious 2020 Presidential Awards, which recognizes individuals and teams from the University and Health Syste
Duke clinicians examine intersections between neurology, neurosurgery, and women's health
Gender has profound, complex effects across all fields of health, and the fields of neurology and neurosurgery are no exception.
Duke clinicians examine intersections between neurology, neurosurgery, and women's health
Gender has profound, complex effects across all fields of health, and the fields of neurology and neurosurgery are no exception.
Duke Institute for Health Innovation announces 2021 Innovation Awards
Duke Health leaders have selected ten high-potential innovation projects to be implemented as part of the Duke Institute for Health Innovation (DIHI)’s annual call f